Frontlight ResearchEarly access
Trial site
Kitasato University Kitasato Institute Hospital
- 9running trials
- 3closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis10 trials
- Crohn's disease3 trials
- Phase
- Phase 37 trials
- Phase 23 trials
- Phase 2/32 trials
- Status
- Active, not recruiting7 trials
- Completed3 trials
- Recruiting2 trials
- Lead sponsor
- Janssen Research & Development, LLC5 trials
- Abivax S.A.2 trials
- Eli Lilly and Company2 trials
- Alfasigma S.p.A.1 trial
- Gilead Sciences1 trial
- and 1 more
Running trials
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026